MULTI-COMPONENT ELECTROSPUN FIBER SCAFFOLDS
A scaffold may comprise a first polymeric electrospun fiber comprising a first material having a first degradation rate, and a second polymeric electrospun fiber comprising a second material having a second degradation rate different from the first degradation rate. The first degradation rate may substantially correspond to a cell infiltration rate, and the second degradation rate may be slower than the first degradation rate. Such a scaffold may be manufactured by electrospinning a first polymer fiber having a first degradation rate by ejecting a first polymer solution from a first polymer injection system onto a mandrel, and electrospinning a second polymer fiber having a second degradation rate different from the first degradation rate by ejecting a second polymer solution from a second polymer injection system onto a mandrel. Wound healing may be improved by applying such a scaffold to a portion of a wound.
1 . A method of improving wound healing, comprising:
applying to a portion of a wound a scaffold comprising:
a first polymeric electrospun fiber consisting of a first material; and
a second polymeric electrospun fiber consisting of a second material;
wherein the first polymeric electrospun fiber has a diameter from about 0.5 μm to about 5 μm, and is configured to completely degrade within a first period of time in phosphate buffered saline at about 37 degrees Celsius;
wherein the second polymeric electrospun fiber has a diameter from about 0.5 μm to about 5 μm, and is configured to completely degrade within a second period of time in phosphate buffered saline at about 37 degrees Celsius; and
wherein the first period of time is from about 1 week to about 4 weeks, and wherein the second period of time is from about 4 weeks to about 24 weeks.
2 . The method of claim 1 , wherein the first material and the second material are independently selected from the group consisting of polycaprolactone, chitosan, polydioxanone, polyglycolide, poly (lactide-co-caprolactone), poly (lactide-co-glycolide), poly-L-lactide, and combinations thereof.
3 . The method of claim 1 , wherein the first material is polyglycolide and the second material is poly (lactide-co-caprolactone).
4 . The method of claim 1 , wherein the first polymeric electrospun fiber and the second polymeric electrospun fiber are present in a weight ratio selected from the group consisting of 1:1, 2:1, 3:1, 1:2, and 1:3.
5 . The method of claim 1 , wherein the first polymeric electrospun fiber and the second polymeric electrospun fiber are present in a weight ratio of about 1:1.
6 . The method of claim 1 , wherein the first polymeric electrospun fiber and the second polymeric electrospun fiber are co-spun.
7 . The method of claim 1 , wherein the first period of time is from about 2 times to about 24 times shorter than the second period of time.
8 . The method of claim 1 , wherein the first period of time substantially corresponds to a cell infiltration rate, and wherein the second period of time is substantially longer than the first degradation rate.
9 . The method of claim 1 , further comprising preseeding the scaffold with at least one biological cell selected from the group consisting of a differentiated cell, a multipotent stem cell, a pluripotent stem cell, a totipotent stem cell, an autologous cell, a syngeneic cell, an allogeneic cell, a bone marrow-derived stem cell, a cord blood stem cell, a mesenchymal cell, an embryonic stem cell, an induced pluripotent stem cell, an epithelial cell, an endothelial cell, a hematopoietic cell, an immunological cell, and any combination thereof.
10 . The method of claim 1 , further comprising soaking the scaffold in a treatment selected from the group consisting of platelet-rich plasma, bone marrow, stromal vascular fraction, and combinations thereof.